Advertisement
HSIC vs VTR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Hold and VTR is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HSIC’s FA Score shows that 0 FA rating(s) are green whileVTR’s FA Score has 1 green FA rating(s).
- HSIC’s FA Score: 0 green, 5 red.
- VTR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HSIC’s TA Score shows that 5 TA indicator(s) are bullish while VTR’s TA Score has 3 bullish TA indicator(s).
- HSIC’s TA Score: 5 bullish, 6 bearish.
- VTR’s TA Score: 3 bullish, 5 bearish.
Price Growth
HSIC (@Medical Distributors) experienced а +1.20% price change this week, while VTR (@Managed Health Care) price change was -0.80% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +0.56%. For the same industry, the average monthly price growth was +2.83%, and the average quarterly price growth was +0.25%.
The average weekly price growth across all stocks in the @Managed Health Care industry was +1.41%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +13.89%.
Reported Earning Dates
HSIC is expected to report earnings on Nov 04, 2025.
VTR is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Medical Distributors (+0.56% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
@Managed Health Care (+1.41% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| HSIC | VTR | HSIC / VTR | |
| Capitalization | 8.28B | 30.9B | 27% |
| EBITDA | 932M | 2.07B | 45% |
| Gain YTD | -1.286 | 17.107 | -8% |
| P/E Ratio | 21.96 | 158.05 | 14% |
| Revenue | 12.8B | 5.3B | 241% |
| Total Cash | 145M | 614M | 24% |
| Total Debt | 3.36B | 13.3B | 25% |
HSIC | VTR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 28 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 36 | |
P/E GROWTH RATING 1..100 | 72 | 95 | |
SEASONALITY SCORE 1..100 | 75 | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VTR's Valuation (61) in the Real Estate Investment Trusts industry is in the same range as HSIC (74) in the Medical Distributors industry. This means that VTR’s stock grew similarly to HSIC’s over the last 12 months.
VTR's Profit vs Risk Rating (28) in the Real Estate Investment Trusts industry is significantly better than the same rating for HSIC (100) in the Medical Distributors industry. This means that VTR’s stock grew significantly faster than HSIC’s over the last 12 months.
VTR's SMR Rating (100) in the Real Estate Investment Trusts industry is in the same range as HSIC (100) in the Medical Distributors industry. This means that VTR’s stock grew similarly to HSIC’s over the last 12 months.
VTR's Price Growth Rating (36) in the Real Estate Investment Trusts industry is in the same range as HSIC (62) in the Medical Distributors industry. This means that VTR’s stock grew similarly to HSIC’s over the last 12 months.
HSIC's P/E Growth Rating (72) in the Medical Distributors industry is in the same range as VTR (95) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew similarly to VTR’s over the last 12 months.
| HSIC | VTR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 40% | 2 days ago 46% |
| Stochastic ODDS (%) | 2 days ago 68% | 2 days ago 50% |
| Momentum ODDS (%) | 2 days ago 58% | 2 days ago 52% |
| MACD ODDS (%) | 2 days ago 51% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 53% | 2 days ago 63% |
| Advances ODDS (%) | 8 days ago 52% | 16 days ago 63% |
| Declines ODDS (%) | 3 days ago 55% | 7 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 68% | N/A |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 59% |
Advertisement
HSIC and
Correlation & Price change
A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.
| Ticker / NAME | Correlation To HSIC | 1D Price Change % | ||
|---|---|---|---|---|
| HSIC | 100% | +1.62% | ||
| ZYXI - HSIC | 30% Poorly correlated | +2.63% | ||
| OMI - HSIC | 22% Poorly correlated | -1.65% | ||
| CAH - HSIC | 20% Poorly correlated | -0.47% | ||
| COR - HSIC | 18% Poorly correlated | +1.50% | ||
| QIPT - HSIC | 17% Poorly correlated | -3.98% | ||
More | ||||
VTR and
Correlation & Price change
A.I.dvisor indicates that over the last year, VTR has been closely correlated with WELL. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTR jumps, then WELL could also see price increases.
| Ticker / NAME | Correlation To VTR | 1D Price Change % | ||
|---|---|---|---|---|
| VTR | 100% | +1.12% | ||
| WELL - VTR | 78% Closely correlated | +0.71% | ||
| PLD - VTR | 67% Closely correlated | +5.05% | ||
| NHI - VTR | 66% Loosely correlated | +1.66% | ||
| SBRA - VTR | 63% Loosely correlated | +1.50% | ||
| OHI - VTR | 62% Loosely correlated | +1.25% | ||
More | ||||